Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders.

For more information please use the contact details below.